The LFSS has created a new accreditation system for #teleconsultation companies, aiming to ensure that teleconsulta… twitter.com/i/web/status/1…

In our latest BioTalk article, Deirdre Kilroy and Georgina Parkinson consider the NIS2 and CER Directive, and the i… twitter.com/i/web/status/1…

It’s out! We are delighted to announce that we have published the 8th edition of the Guide to EU & UK… twitter.com/i/web/status/1…

The CJEU has provided welcome new guidance on when parallel importers can rebrand generic medicines with the origin… twitter.com/i/web/status/1…

It was a pleasure to host the @BIA_UK Women in Biotech London event at our office last night. Fantastic speakers an… twitter.com/i/web/status/1…

RT @twobirdsIP: We are sponsoring LSPN Europe in London on 29th November! Join Chris de Mauny where he will be talking about the latest on…

The UK’s Medicines & Healthcare products Regulatory Agency (MHRA) has recently announced the introduction of a 12-m… twitter.com/i/web/status/1…

The European Commission has proposed new rules to increase safety and quality of substances of human origin, which… twitter.com/i/web/status/1…

The French Clinical Trial Agreement templates were recently updated to ensure #GDPR compliance and have now been tr… twitter.com/i/web/status/1…